Italia markets closed

ILMN Jun 2024 105.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
4,4800+0,2800 (+6,67%)
In data: 02:57PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente4,2000
Aperto4,5000
Denaro4,1000
Lettera4,5000
Prezzo d'esercizio105,00
Scadenza2024-06-21
Min-Max giorno4,3000 - 4,5000
Contratto - Min-MaxN/D
Volume8
Open Interest257
  • GlobeNewswire

    Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

    Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only testSALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, to advance and support clinical research for gene-based, targeted thera